Trial intelligence / Profile preview

Pyridostigmine for Orthostatic Hypotension in SCI

NCT02307526Phase 2Completed

Sponsor
James J. Peters Veterans Affairs Medical Center
Start
Jan 2011
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pyridostigmine in orthostatic hypotension (OH), sponsored by James J. Peters Veterans Affairs Medical Center. Started Jan 2011; status: completed.

02

Drugs

pyridostigmine
03

Conditions

orthostatic hypotension (OH)

Beyond the preview

Go deeper on NCT02307526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02307526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call